Bank of New York Mellon’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.31M | Buy |
343,524
+2,749
| +0.8% | +$58.5K | ﹤0.01% | 2049 |
|
|
2025
Q1 | $6.57M | Buy |
340,775
+7,265
| +2% | +$140K | ﹤0.01% | 2060 |
|
|
2024
Q4 | $5.95M | Buy |
333,510
+84,117
| +34% | +$1.5M | ﹤0.01% | 2193 |
|
|
2024
Q3 | $5.46M | Sell |
249,393
-30,972
| -11% | -$678K | ﹤0.01% | 2253 |
|
|
2024
Q2 | $2.19M | Sell |
280,365
-21,334
| -7% | -$166K | ﹤0.01% | 2745 |
|
|
2024
Q1 | $1.25M | Sell |
301,699
-40,830
| -12% | -$169K | ﹤0.01% | 3026 |
|
|
2023
Q4 | $894K | Buy |
342,529
+24,199
| +8% | +$63.2K | ﹤0.01% | 3244 |
|
|
2023
Q3 | $595K | Hold |
318,330
| – | – | ﹤0.01% | 3450 |
|
|
2023
Q2 | $799K | Buy |
318,330
+272,892
| +601% | +$685K | ﹤0.01% | 3329 |
|
|
2023
Q1 | $79.5K | Buy |
45,438
+24,327
| +115% | +$42.6K | ﹤0.01% | 4105 |
|
|
2022
Q4 | $89.7K | Buy |
+21,111
| New | +$89.7K | ﹤0.01% | 4136 |
|
|
2022
Q2 | – | Sell |
-49,763
| Closed | -$122K | – | 4683 |
|
|
2022
Q1 | $122K | Hold |
49,763
| – | – | ﹤0.01% | 4366 |
|
|
2021
Q4 | $134K | Buy |
49,763
+4,971
| +11% | +$13.4K | ﹤0.01% | 4359 |
|
|
2021
Q3 | $224K | Buy |
44,792
+7,678
| +21% | +$38.4K | ﹤0.01% | 4157 |
|
|
2021
Q2 | $277K | Buy |
+37,114
| New | +$277K | ﹤0.01% | 3984 |
|
|
2020
Q1 | – | Sell |
-216,897
| Closed | -$347K | – | 4173 |
|
|
2019
Q4 | $347K | Hold |
216,897
| – | – | ﹤0.01% | 3741 |
|
|
2019
Q3 | $388K | Hold |
216,897
| – | – | ﹤0.01% | 3681 |
|
|
2019
Q2 | $274K | Buy |
216,897
+118,501
| +120% | +$150K | ﹤0.01% | 3827 |
|
|
2019
Q1 | $180K | Buy |
+98,396
| New | +$180K | ﹤0.01% | 3898 |
|